183997-134x178.jpg

March 2016

Volume 19, Issue 2

 

Issue's short description comes here.

 

Browse other issues »Subscribe to our print issues »

Articles in this Issue

  • Development of a New Delivery Modality Based on Oral-Soluble Postage Stamp Size Films

    Zheng Lu, Reza Fassihi
    In recent years, many scientists in the pharmaceutical industry are focusing part of their research activity on the development and use of oral strip technology (OST).
  • Raman Spectral Fingerprinting For Biologics Counterfeit Drug Detection

    Jeremy Peters, Anna Luczak, PhD, Varsha Ganesh, Eugene Park, Ravi Kalyanaraman, Ph.D.
    Counterfeit drugs pose a significant and fast-growing threat to public health and safety. The incident of counterfeit Avastin® in the United States demonstrates the vulnerability of the supply chain even in developed countries. Government health agencies and pharma-ceutical manufacturers are finding ways to fight counterfeit and substandard drugs by identifying them from manufacturing, throughout the supply chain, and eventually when they reach the public in the retail pharmacies.
  • Nice Insight Outsourcing Trends in 2016

    Nigel Walker
    Moving into 2016, the outlook for outsourcing is brighter than ever as pharmaceutical and biotechnology companies continue to rely more heavily on external service providers for research, development and manufacturing services. According to a new 2016 Nice Insight CRO and CDMO Outsourcing survey of 1,173 industry representatives from pharma and biotech companies, spending for outsourced services takes a big leap compared to previous years.
  • A Tale of Two Drug Delivery Strategies: Simple Solubilization or Sophisticated Supersaturation?

    John Morrison, PhD
    Contemporary small molecule therapeutics are often hindered by poor physicochemical properties, with high lipophilicity and/or crystallinity leading to poor aqueous solubility. This in turn limits oral absorption resulting in low or variable systemic exposure. While the concept of poor solubility is well understood, a practical definition is more complex. The USP-NF defines several categories of solubility limits. For instance, the lowest category deems a compound to be practically insoluble/insoluble if the solubility is less than 0.1mg/mL in water.
  • Impact from the Recent Issuance of ANVISA Resolution RDC-53/2015 on Pharmaceutical Small Molecule...

    Peter Tattersall, Suwimon Asawasiripong, PhD, Ivone Takenaka, PhD, John A. Castoro, PhD,
    Forced degradation studies (FDS) are essential in the development of stability indicating methods to gain understanding of the intrinsic stability characteristics of a Drug Substance (DS). Performance of stress studies under various conditions allows prediction of the possible degradants that may be obtained during registrational long term stability studies (LTSS). These degradants are used to develop and validate the selectivity required for registrational DS and drug product (DP) analytical methods. New molecular entity registrational filings require discussion of forced degradation data in stability indicating methods (SIM) validation and degradation mechanistic stability sections along with any relevant controls in both synthesis and the formulation sections of the Health Authority dossier submission.
  • Bias: The Hidden Danger to Your Risk Assessment

    Paula Peacos
    Quality risk management (QRM) is a systematic process for the assessment, control, communication and review of risks to the quality of a product or process over the entire product lifecycle. An effective QRM program can ensure high quality of a given process or product by providing a proactive means to identify and control potential quality issues during development and production. QRM can also improve the quality of decision making. (ICH Q9 2005).
  • An Interview With... Zak Yusoff, PMP Senior Product Development Manager SP Scientific, a Division...

    Substantial advancements in lyophilization technology have occurred in the last five years namely as a result of research related to the lyophilization process and the incorporation of this knowledge into development tools and equipment design. These advances have resulted in new ways to approach product development or product remediation. One particular example is the use of Manometric Temperature Measurement (MTM) technique during the lyophilization process to accurately determine product characteristics such as product temperature at the sublimation interface, dry layer thickness, product resistance, sublimation rate and other important data across a product batch under certain process conditions.
  • Modulation of Carboxylesterase-Mediated Drug Metabolism by Natural Products

    M. Jason M. Jason, Philip M. Potter
    Carboxylesterases (CE) are ubiquitous enzymes that metabolize ester-containing compounds into the corresponding alcohols and carboxylic acids. This is primarily thought to be a detoxifi cation process for xenobiotics since the proteins are principally localized in cells and tissues likely to be exposed to such agents. However, ester chemotypes signifi cantly improve the water solubility of molecules and hence the strategy of including these functions in poorly soluble drugs is widely employed in the pharmaceutical industry.
  • Pharmaceutical Facility Sanitization: Best Practices Considered

    Tim Sandle, PhD
    Cleanrooms and clean areas must be regularly cleaned and disinfected. This is normally undertaken using a detergent step, followed by the application of a disinfectant. It may be necessary to remove the residue of the disinfectant using water. Cleaning and disinfection should also extend to equipment. Furthermore, with personnel, sanitization is important in relation to glove hands.
  • Single-Use/Disposables Technologies and Equipment Roundtable

    Consumable or single-use operating costs will far exceed the initial capital investment, so do not lock yourself into a single-source situation, especially on the bag fi lms and tubing sets. Qualify at least two vendors for each unit operation of your processes to ensure security of supply chain and price. Consider using “universal controllers” for each unit operation to facilitate the interchange of bioreactors, fi lters, and chromatography columns
  • <<
  • >>